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It is essential to bear in mind that the
native conformation of human proteins
is stabilized by intra-molecular disulﬁde
(S–S) bonds between a single or multiple
polypeptide chains. The formation of S–S
bonds is catalyzed by protein disulﬁde iso-
merase (PDI) (1), the activation of which
is associated with a number of human dis-
eases,suchasmyocardialinfarction,stroke,
and cancer. Unless proper chaperone pro-
teins are available the accidental cleavage
of S–S linkages will result in the unfolding
andscrambledrefoldingofthepolypeptide
chains thus producing non-native species
present in many degenerative diseases (2–
5). This process is the most common pro-
tein post-translational modiﬁcation that,
for example, in a protein with 9 disulﬁde
bridges can theoretically form 34,459,425
different disulﬁde-bonded isomers, only
one with a correct protein function. How-
ever, the most damaging consequence of
such a modiﬁcation is the formation of
protein aggregates known as “inclusion
bodies” that are resistant to the enzymatic
degradation (6). This unusual phenome-
non is the result of the formation of inter-
molecular hydrophobic bonds, which in
contrasttopeptidelinksarenotsusceptible
to the catalytic hydrolysis. It is known that
the strongest and practically irreversible
protein interactions involve hydrophobic
bonds, which in native proteins are buried
inside their tertiary structure (7).
One of the blood proteins rich in disul-
ﬁdes is ﬁbrinogen (Fbg), the physiologic
function of which is to provide hemo-
static ﬁbrin plug formed by the action
of enzyme thrombin. This insoluble poly-
mer, when formed at the site of vessel
wall injury, is eventually removed by the
action of ﬁbrinolytic enzyme system, to
give space for the growth of a connec-
tive tissue and to ensure proper wound
healing. To speed up the process of ﬁbrin
elimination from the coronary or cerebral
circulations, several thrombolytic thera-
pies have been devised with the use of a
variety of ﬁbrinolytic agents. It is, how-
ever, well recognized in clinical practice
that such therapies are effective only when
installed 3–5h after the onset of throm-
bosis (8). This enigma is now resolved
by the discovery of the alternative path-
way of blood coagulation induced with
iron (9). Thus, in contrast to thrombin-
generated ﬁbrin the iron-induced paraﬁb-
rin is totally resistant to the ﬁbrinolytic
degradation. This is due to the fact that
paraﬁbrin has different a tertiary structure
thanﬁbrinformedwiththrombin.Wehave
showed that such a dramatic modiﬁcation
of ﬁbrin structure is due to the unfolding
and scrambled refolding of Fbg disulﬁde-
linked subunits leading to the exposure of
hydrophobic epitopes in their polypeptide
chains (9). The cleavage of disulﬁde bonds
is induced by biologically highly reactive
hydroxylradicals(HO)formedinthereac-
tion between trivalent iron with hydroxyl
groups of water according to the following
formula:
Fe3C C HO  ! Fe2C C HO.
Astheconsequenceof thehydroxylrad-
ical interaction with Fbg a huge protease
resistant polymer is formed that remains
in the circulation for a long time, result-
ing in a state of chronic inﬂammation due
to the attraction of cytotoxic albeit inef-
fective T cells. The accumulating evidence
indicatesthatthereisacorrelationbetween
increasedbloodconcentrationof unbound
ironandtheincidenceof cancerinhumans
(10–13), and that its reduction may pre-
vent cancer morbidity and mortality (14).
It should be noted that it is only the triva-
lent iron (Fe3C), and not divalent (Fe2C),
which participate in the generation of
hydroxyl radicals and subsequent forma-
tion of insoluble paraﬁbrin from soluble
plasma Fbg. However, when hemoglobin
is released from the hemolyzed erythro-
cytes, the divalent ferrous ions are enzy-
matically converted to ferric ions. Thus,
anypathologicconditioninwhicherythro-
cytemembranesaredamaged,e.g.,ininfec-
tionsand/orafterexposuretoenvironmen-
tal toxins, may contribute to the excessive
body storage of trivalent iron. It should be
borne in mind that this form of iron accu-
mulateswithageduetothefactthatthereis
no mechanism for its physiologic elimina-
tion,andmaytherefore,explainassociation
of cancer with aging.
The unsuccessful attempts at removing
paraﬁbrin by the human body defense sys-
tems were recently suggested to contribute
toAlzheimer’s disease (15) as well as to the
cardiovascular disease (16). These diseases
andotherdegenerativedisordershavebeen
known to respond well to dietary mod-
iﬁcations, particularly to those associated
withtheso-calledMediterraneandiet(17),
which is rich in natural amphiphilic sub-
stances such as polyphenols and ﬂavones.
Relevant to the concept presented in this
article is the fact that protein unfold-
ing can be inhibited by natural products
present in tea, fruits, berries, and certain
grains,theconsumptionof whichisknown
to lower the incidence of degenerative
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FIGURE 1 | Schematic presentation of a putative mechanism of the anticancer effect of
amphiphilic substances that displace paraﬁbrin from surface of the cancer cell membrane.
diseases (18). In addition, there is another
importantcomponentof humandiet,sele-
nium, which is known to prevent various
forms of cancer (19–23). Hence, sodium
selenite, but not selenate, reacts with free
sulfhydrylgroupsofproteins,thusprevent-
ing reductive cleavage of disulﬁde bonds
followed by protein unfolding and abnor-
mal refolding (24,25).
It is proposed in this paper that the bar-
rier formed around tumor cells composed
of proteolytically resistant paraﬁbrin can
be removed by a non-enzymatic mecha-
nismbasedontheinteractionofhydropho-
bic and hydrophilic groups (Figure 1).
Numerous natural substances, particu-
larly those of amphiphilic nature such as
polyphenols, when ingested with diet in
sufﬁcient quantities can prevent and/or
reverse cancer formation and metastases
(26–33). These ﬁndings may explain ben-
eﬁcial effects of the Mediterranean diet
known to be associated with lower inci-
dence of cancer and other degenerative
diseases (34).
According to the mechanism shown
in Figure 1 amphiphilic substances taken
up with food interfere with and/or dis-
place the hydrophobic coat on cancer cells
membranesthusexposingneoantigensand
making tumors vulnerable to the natural
killer cells attack and lysis.
In conclusion, the concept delineated
in this article supports the original notion
expressed by Basmadijan et al. (35)
according to which natural products have
a potential to be developed into novel
anticancer medicines.
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